Page URL:

Rare form of autism treated with dietary supplement

10 September 2012
Appeared in BioNews 672

A rare form of autism, caused by a mutation that alters amino acid metabolism, could potentially be treated with a nutritional supplement, according to an international team of researchers. This finding may also lead to an effective test for the condition using genetic biomarkers, helping earlier and more accurate diagnosis.

'This might represent the first treatable form of autism', Professor Joseph Gleeson of the University of California, San Diego, who led the study, said to the journal Nature. 'That is both heartening to families with autism, and also I think revealing of the underlying mechanisms of autism'.

Around a quarter of people with autism spectrum disorder also present with epilepsy. Researchers analysed the DNA of three families from the Middle East with children who have autism spectrum disorder with epilepsy, specifically focusing on the regions of their DNA that code for proteins. The children in question, who all had parents who were first cousins, carried a mutation in a gene called BCKDK.

BCKDK prevents the breakdown of specific amino acids, known as branched chain amino acids (BCAAs). These are essential amino acids that have to be obtained from our diet. The children with mutant BCKDK broke down these amino acids more quickly, leading to a deficiency.

Mice engineered to have the same genetic flaw, who had tremors and epileptic seizures, were given food supplemented with BCAAs. Their symptoms subsequently improved, leading scientists to posit whether supplementing the diet of the people with this particular mutation could also alleviate their symptoms.

'Studying the animals was key to our discovery', said lead author Dr Gaia Novarino of the University of California, San Diego. 'We found that the mice displayed a condition very similar to our patients, and also had spontaneous epileptic seizures, just like our patients. Once we found that we could treat the condition in mice, the pressing question was whether we could effectively treat our patients'.

Researchers showed that an over-the-counter supplement did reverse the amino acid deficiency in the autistic children, without causing any adverse effects. Future work will investigate whether the supplement can indeed reduce the patients symptoms of epilepsy and autism.

The type of autism addressed in the study is very rare and these particular results may not therefore be applicable to other forms of autism. However, studying other metabolic pathways may be of benefit, suggests Dr Daniel Geschwind, a neurogeneticist at the University of California, Los Angeles.

'If five or ten percent [of autism cases] are caused by metabolic disorders and there's a simple imbalance that one can correct with nutrition, that's something that human genetics will identify over the next five to ten years'.

The study was published in the journal Science.

Amino-acid deficiency underlies rare form of autism
Nature News |  6 September 2012
Mutations in BCKD-kinase Lead to a Potentially Treatable Form of Autism with Epilepsy
Science |  6 September 2012
Nutritional Supplement Offers Promise in Treatment of Unique Form of Autism
UC San Diego Health System (press release) |  6 September 2012
Rare Autism Form May Improve With Diet Change, Study Says
Bloomberg News |  6 September 2012
Treating autism with dietary supplements
The Guardian |  7 September 2012
21 January 2013 - by Dr Victoria Burchell 
Rare genetic variants may have a significant impact on a person's risk of developing autism, research suggests...
17 September 2012 - by Dr Victoria Burchell 
A genetic test capable of predicting a person's risk of Autism Spectrum Disorders (ASDs), with an accuracy greater than 70 percent, has been developed by researchers...
28 August 2012 - by Nishat Hyder 
Stem cells harvested from patients' own umbilical cord blood are to be trialled in the US as treatment for children with autism...
16 April 2012 - by James Brooks 
Genetic mutations that occur spontaneously in sperm and egg cells may increase a child's risk of autism, say scientists...
25 July 2011 - by Mehmet Fidanboylu 
Children with autism and their siblings share similar patterns of reduced activity in brain regions linked to empathy, according to new research carried out at the University of Cambridge, UK. The researchers believe these findings could lead to a greater understanding of the role of genes in autism and the development of techniques for predicting the risk of developing autism in the future....
13 June 2011 - by Dr Lux Fatimathas 
American researchers have linked hundreds of spontaneous genetic mutations to the group of psychological syndromes called autism spectrum disorders (ASDs)...
31 May 2011 - by Mehmet Fidanboylu 
Gene activity in two brain regions is different in autism, scientists say. A US study found activity patterns were similar in the frontal and temporal lobes of people with autism, despite the lobes having different functions...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.